Study coauthor Alan O’Neill, a microbiologist in Gallo’s lab, tells The Scientist that the paper “provides a new mechanism of action for a very important drug in the treatment of acne. This drug is ...

and flaring of acne. Because of the risk of teratogenicity, women of childbearing age must not become pregnant while exposed to isotretinoin. The mechanism of action of isotretinoin is not ...

TVB-3567 is the Company’s second fatty acid synthase (FASN) inhibitor First-in-human Phase 1 trial initiation planned in 2025 ...

Clinical studies have shown that isotretinoin can lead to significant and long-lasting clearance of acne, often resulting in ...

Dermata Therapeutics, Inc. (Nasdaq: DRMA, DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin diseases and conditions, today ...

Based on both its mechanism of action and strong preclinical profile, we believe TVB-3567 has the potential to offer a differentiated treatment option for acne. We look forward to initiating ...

Acne therapy with retinoids can be frustrating ... has been studied for patients with oropharyngeal carcinoma. The mechanism of action of vitamin A modulates growth and differentiation of cells ...

Sagimet Biosciences (SGMT) announced the clearance of its Investigational New Drug, IND, application for TVB-3567, the Company’s second fatty ...